文献速递肿瘤 PET/CT放射性药物与辐射防护

PET/MRI 改善儿童癌症管理

PET/MRI Improves Management of Children with Cancer.
PubMed 文献 · J Nucl Med · 2021-01-01

本文综述了18F-FDG PET/MRI在儿童肿瘤中的应用,指出其可一站式提供功能与解剖评估,且辐射暴露较18F-FDG PET/CT降低可达80%。来自4家机构的早期使用者分享了PET/MRI在软组织与骨髓评估、鉴别肿瘤与感染/炎症、以及改善淋巴瘤、肉瘤和神经纤维瘤病临床管理方面的价值,并展望了免疫治疗评估与诊疗一体化药物应用。

要点

  • PET/MRI可一站式完成儿童肿瘤分期与再分期,辐射暴露较PET/CT降低可达80%。
  • 全身PET/MRI通过减少所需影像检查次数改善淋巴瘤、肉瘤和神经纤维瘤病的管理。
  • PET/MRI有助于鉴别恶性肿瘤与感染性或炎症性疾病。

核心结论

  • 整合PET/MRI对儿童癌症的分期与再分期具有显著临床价值,可提供一站式功能与解剖肿瘤评估。

研究设计与样本

  • 本文为综述,汇总4家机构早期使用者的经验,讨论18F-FDG PET/MRI在儿童肿瘤中的临床应用。

主要发现

  • 与18F-FDG PET/CT相比,PET/MRI辐射暴露降低可达80%。
  • 全身PET/MRI在软组织与骨髓等解剖区域评估中有价值,并具有儿童患者特定的判读特征。
  • 全身PET/MRI通过减少所需放射学检查次数(从而降低辐射暴露)而不损失诊断准确性,改善淋巴瘤、肉瘤和神经纤维瘤病患儿的管理。
  • PET/MRI有助于鉴别恶性肿瘤与感染性或炎症性疾病。

关键数值与推荐

  • 与18F-FDG PET/CT相比,PET/MRI辐射暴露降低可达80%。

临床怎么用

  • 可将全身18F-FDG PET/MRI用于儿童肿瘤的分期与再分期,以减少检查次数和辐射暴露。
  • 在儿童患者中判读PET/MRI时需注意其特定的判读特征。
  • 可利用PET/MRI鉴别恶性肿瘤与感染性或炎症性疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Integrated PET/MRI has shown significant clinical value for staging and restaging of children with cancer by providing functional and anatomic tumor evaluation with a 1-stop imaging test and with up to 80% reduced radiation exposure compared with 18F-FDG PET/CT. This article reviews clinical applications of 18F-FDG PET/MRI that are relevant for pediatric oncology, with particular attention to the value of PET/MRI for patient management. Early adopters from 4 different institutions share their insights about specific advantages of PET/MRI technology for the assessment of young children with cancer. We discuss how whole-body PET/MRI can be of value in the evaluation of certain anatomic regions, such as soft tissues and bone marrow, as well as specific PET/MRI interpretation hallmarks in pediatric patients. We highlight how whole-body PET/MRI can improve the clinical management of children with lymphoma, sarcoma, and neurofibromatosis, by reducing the number of radiologic examinations needed (and consequently the radiation exposure), without losing diagnostic accuracy. We examine how PET/MRI can help in differentiating malignant tumors versus infectious or inflammatory diseases. Future research directions toward the use of PET/MRI for treatment evaluation of patients undergoing immunotherapy and assessment of different theranostic agents are also briefly explored. Lessons learned from applications in children might also be extended to evaluations of adult patients.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Baratto L, Hawk KE, States L, et al. PET/MRI Improves Management of Children with Cancer. J Nucl Med. 2021. PMID: 34599010. doi:10.2967/jnumed.120.259747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。